Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma

31 Jan 2023

Abstract excerpt

BACKGROUND: Early diagnosis of lung adenocarcinoma (LUAD), one of the most common types of lung cancer, is very important to improve the prognosis of patients. The current methods can't meet the requirements of early diagnosis. There is a pressing need to identify novel diagnostic biomarkers. Secretory proteins are the richest source for biomarker research. This study aimed to identify candidate secretory protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Chemokine receptors and signaling
Share to Clusterin in disease pathology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36721112
DOI: 10.1186/s12885-023-10523-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinomaPMID 36721112Read ↗

WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma.Semantic proximity Read ↗

Identification and validation of plasma exosomal FGL1 as an early diagnostic biomarker for non-small cell lung cancerSemantic proximity Read ↗

Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read ↗

Identidication of novel biomarkers in non-small cell lung cancer using machine learningSemantic proximity Read ↗

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerSemantic proximity Read ↗

Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinomaSemantic proximity Read ↗

Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinomaSemantic proximity Read ↗

Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung AdenocarcinomaSemantic proximity Read ↗

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axisSemantic proximity Read ↗

Assessment of ACE2, CXCL10 and Their co-expressed Genes: An In-silico Approach to Evaluate the Susceptibility and Fatality of Lung Cancer Patients towards COVID-19 InfectionSemantic proximity Read ↗

Comprehensively analysis of the FGD family with potential effects on prognosis and immune infiltration in lung adenocarcinomaSemantic proximity Read ↗

Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.